Post-transfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction

被引：94

作者：

Ito, Y

Niwa, H

Iida, T

Nagamatsu, M

Yasuda, T

Yanagi, T

Sobue, G

机构：

[1] NAGOYA UNIV,SCH MED,DEPT NEUROL,SHOWA KU,NAGOYA,AICHI 466,JAPAN

[2] NAGOYA UNIV,SCH MED,DEPT GYNECOL,NAGOYA,AICHI 466,JAPAN

[3] NAGOYA DAINI RED CROSS HOSP,DEPT NEUROL,NAGOYA,AICHI,JAPAN

来源：

NEUROLOGY | 1997年 / 49卷 / 04期

关键词：

D O I：

10.1212/WNL.49.4.1174

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：1174 / 1175

页数：2

共 7 条

[1] SEIZURES IN DIALYSIS PATIENTS TREATED WITH RECOMBINANT ERYTHROPOIETIN - REVIEW OF THE LITERATURE AND GUIDELINES FOR PREVENTION [J].

BECCARI, M .

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1994, 17 (01) :5-13

[2] SEIZURES RELATED TO BLOOD-TRANSFUSION AND ERYTHROPOIETIN TREATMENT IN PATIENTS UNDERGOING DIALYSIS [J].

BROWN, AL ;

TUCKER, B ;

BAKER, LRI ;

RAINE, AEG .

BRITISH MEDICAL JOURNAL, 1989, 299 (6710) :1258-1259

[3] BENEFITS AND RISKS OF PROTRACTED TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS HAVING HEMODIALYSIS [J].

CASATI, S ;

PASSERINI, P ;

CAMPISE, MR ;

GRAZIANI, G ;

CESANA, B ;

PERISIC, M ;

PONTICELLI, C .

BMJ-BRITISH MEDICAL JOURNAL, 1987, 295 (6605) :1017-1020

[4] CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL [J].

ESCHBACH, JW ;

EGRIE, JC ;

DOWNING, MR ;

BROWNE, JK ;

ADAMSON, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) :73-78

[5] A reversible posterior leukoencephalopathy syndrome [J].

Hinchey, J ;

Chaves, C ;

Appignani, B ;

Breen, J ;

Pao, L ;

Wang, A ;

Pessin, MS ;

Lamy, C ;

Mas, JL ;

Caplan, LR .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :494-500

[6]

Jenner PW, 1996, CLIN PRACTICE TRANSF, P905

[7]

TOMSON CRV, 1988, LANCET, V2, P351

← 1 →